WuXi Biologics (Cayman) Inc. WuXi Biologics (Cayman) Inc.

WuXi Biologics (Cayman) Inc.

2269

Rang in aandelen #991
Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman)... Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman) Inc. delivers a comprehensive, integrated suite of services spanning the entire biologics lifecycle, from initial discovery through development to large-scale manufacturing. The company's operations have a global footprint, serving clients across the People's Republic of China, North America, Europe, and other international regions. Its diversified offerings also include specialized consultation in biopharmaceutical technology, international sales contracting, the development and deployment of advanced testing methodologies, and robust marketing and sales support. Furthermore, WuXi Biologics is involved in providing dedicated biologics clinical and manufacturing services, the production and distribution of various medical products, contract development and manufacturing (CDMO) for vaccines and associated businesses, and acting as a supplier of key materials. The firm maintains strategic partnerships with notable entities such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc.
Aandeelprijs
$5.73
Marktkapitalisatie
$23.57B
Verandering (1 dag)
-9.03%
Verandering (1 jaar)
24.25%
Land
CN
Handel WuXi Biologics (Cayman) Inc. (2269)

Categorie

Healthcare
Aandelsplitsingen voor WuXi Biologics (Cayman) Inc. (2269)
Het aandeel WuXi Biologics (Cayman) Inc. (symbool: 2269) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Oct 22, 2026.
Eén aandeel 2269 dat vóór Oct 22, 2026 werd gekocht, staat nu gelijk aan 0 aandelen 2269.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH